Código QR (código de barras bidimensional)

Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report

Abstract Intravenous (i.v.) prostacyclin is the cornerstone treatment in high‐risk pulmonary arterial hypertension (PAH) patients. Selexipag is an orally available prostacyclin receptor agonist. Limited data are available regarding the feasibility of transitioning from i.v. epoprostenol to selexipag...

Fuld beskrivelse

Na minha lista:
Principais autores: André Alexandre, Inês Furtado, Luísa Carvalho, Fabienne Gonçalves, Alzira Melo, Joana Alves, Mário Santos, Abílio Reis
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2023-08-01
Serier:ESC Heart Failure
Fag:
Pulmonary hypertension
Idiopathic pulmonary arterial hypertension
Intravenous epoprostenol
Oral selexipag
Transition therapy
Switchback therapy
Online adgang:https://doi.org/10.1002/ehf2.14428
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker